Cargando…

Research on named entity recognition of adverse drug reactions based on NLP and deep learning

Introduction: Adverse drug reactions (ADR) are directly related to public health and become the focus of public and media attention. At present, a large number of ADR events have been reported on the Internet, but the mining and utilization of such information resources is insufficient. Named entity...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jianxiang, Hu, Tianling, Dai, Jimin, Wang, Ziren, Han, Pu, Huang, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270322/
https://www.ncbi.nlm.nih.gov/pubmed/37332351
http://dx.doi.org/10.3389/fphar.2023.1121796
_version_ 1785059307810717696
author Wei, Jianxiang
Hu, Tianling
Dai, Jimin
Wang, Ziren
Han, Pu
Huang, Weidong
author_facet Wei, Jianxiang
Hu, Tianling
Dai, Jimin
Wang, Ziren
Han, Pu
Huang, Weidong
author_sort Wei, Jianxiang
collection PubMed
description Introduction: Adverse drug reactions (ADR) are directly related to public health and become the focus of public and media attention. At present, a large number of ADR events have been reported on the Internet, but the mining and utilization of such information resources is insufficient. Named entity recognition (NER) is the basic work of many natural language processing (NLP) tasks, which aims to identify entities with specific meanings from natural language texts. Methods: In order to identify entities from ADR event data resources more effectively, so as to provide valuable health knowledge for people, this paper introduces ALBERT in the input presentation layer on the basis of the classic BiLSTM-CRF model, and proposes a method of ADR named entity recognition based on the ALBERT-BiLSTM-CRF model. The textual information about ADR on the website “Chinese medical information query platform” (https://www.dayi.org.cn) was collected by the crawler and used as research data, and the BIO method was used to label three types of entities: drug name (DRN), drug component (COM), and adverse drug reactions (ADR) to build a corpus. Then, the words were mapped to the word vector by using the ALBERT module to obtain the character level semantic information, the context coding was performed by the BiLSTM module, and the label decoding was using the CRF module to predict the real label. Results: Based on the constructed corpus, experimental comparisons were made with two classical models, namely, BiLSTM-CRF and BERT-BiLSTM-CRF. The experimental results show that the F (1) of our method is 91.19% on the whole, which is 1.5% and 1.37% higher than the other two models respectively, and the performance of recognition of three types of entities is significantly improved, which proves the superiority of this method. Discussion: The method proposed can be used effectively in NER from ADR information on the Internet, which provides a basis for the extraction of drug-related entity relationships and the construction of knowledge graph, thus playing a role in practical health systems such as intelligent diagnosis, risk reasoning and automatic question answering.
format Online
Article
Text
id pubmed-10270322
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102703222023-06-16 Research on named entity recognition of adverse drug reactions based on NLP and deep learning Wei, Jianxiang Hu, Tianling Dai, Jimin Wang, Ziren Han, Pu Huang, Weidong Front Pharmacol Pharmacology Introduction: Adverse drug reactions (ADR) are directly related to public health and become the focus of public and media attention. At present, a large number of ADR events have been reported on the Internet, but the mining and utilization of such information resources is insufficient. Named entity recognition (NER) is the basic work of many natural language processing (NLP) tasks, which aims to identify entities with specific meanings from natural language texts. Methods: In order to identify entities from ADR event data resources more effectively, so as to provide valuable health knowledge for people, this paper introduces ALBERT in the input presentation layer on the basis of the classic BiLSTM-CRF model, and proposes a method of ADR named entity recognition based on the ALBERT-BiLSTM-CRF model. The textual information about ADR on the website “Chinese medical information query platform” (https://www.dayi.org.cn) was collected by the crawler and used as research data, and the BIO method was used to label three types of entities: drug name (DRN), drug component (COM), and adverse drug reactions (ADR) to build a corpus. Then, the words were mapped to the word vector by using the ALBERT module to obtain the character level semantic information, the context coding was performed by the BiLSTM module, and the label decoding was using the CRF module to predict the real label. Results: Based on the constructed corpus, experimental comparisons were made with two classical models, namely, BiLSTM-CRF and BERT-BiLSTM-CRF. The experimental results show that the F (1) of our method is 91.19% on the whole, which is 1.5% and 1.37% higher than the other two models respectively, and the performance of recognition of three types of entities is significantly improved, which proves the superiority of this method. Discussion: The method proposed can be used effectively in NER from ADR information on the Internet, which provides a basis for the extraction of drug-related entity relationships and the construction of knowledge graph, thus playing a role in practical health systems such as intelligent diagnosis, risk reasoning and automatic question answering. Frontiers Media S.A. 2023-06-01 /pmc/articles/PMC10270322/ /pubmed/37332351 http://dx.doi.org/10.3389/fphar.2023.1121796 Text en Copyright © 2023 Wei, Hu, Dai, Wang, Han and Huang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wei, Jianxiang
Hu, Tianling
Dai, Jimin
Wang, Ziren
Han, Pu
Huang, Weidong
Research on named entity recognition of adverse drug reactions based on NLP and deep learning
title Research on named entity recognition of adverse drug reactions based on NLP and deep learning
title_full Research on named entity recognition of adverse drug reactions based on NLP and deep learning
title_fullStr Research on named entity recognition of adverse drug reactions based on NLP and deep learning
title_full_unstemmed Research on named entity recognition of adverse drug reactions based on NLP and deep learning
title_short Research on named entity recognition of adverse drug reactions based on NLP and deep learning
title_sort research on named entity recognition of adverse drug reactions based on nlp and deep learning
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270322/
https://www.ncbi.nlm.nih.gov/pubmed/37332351
http://dx.doi.org/10.3389/fphar.2023.1121796
work_keys_str_mv AT weijianxiang researchonnamedentityrecognitionofadversedrugreactionsbasedonnlpanddeeplearning
AT hutianling researchonnamedentityrecognitionofadversedrugreactionsbasedonnlpanddeeplearning
AT daijimin researchonnamedentityrecognitionofadversedrugreactionsbasedonnlpanddeeplearning
AT wangziren researchonnamedentityrecognitionofadversedrugreactionsbasedonnlpanddeeplearning
AT hanpu researchonnamedentityrecognitionofadversedrugreactionsbasedonnlpanddeeplearning
AT huangweidong researchonnamedentityrecognitionofadversedrugreactionsbasedonnlpanddeeplearning